1.Amenta F., DiTullioM.A., Tomassoni D. Arterial hypertension and brain damage-evidence from animal models (review). Clin Exp Hypertens, 2003, vol. 25, no. 6, pp. 359-380.
2.Gasecki D., Kwarciany M., Nyka W., Narkiewicz K. Hypertension, Brain Damage and Cognitive Decline. Curr Hypertens Repo, 2013, vol. 15, no. 6, pp. 547-558.
3.Tzourio, Ch., Debette S. Is Hypertension Associated With an Accelerated Aging of the Brain? Hypertension, 2014, vol. 63, pp. 894-903.
4.Whitmer, R.A.,Sidney S.,Selby J., Johnston S. C., Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 2005, vol. 64, no. 2, pp. 277-281.
5.Napoli, С. Lerman L. O., de Nigris F., Gossl M., Balestrieri M. L., Lerman A. Rethinking Primary Prevention of Atherosclerosis Related Diseases. Circulation, 2006, vol. 114, no. 23, pp. 2517-2527.
6.Doubal F. N., MacGillivray T.J., Patton N., Dhillon B., Dennis M. S., Wardlaw J. M. Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology, 2010, vol. 74, no. 14, pp. 1102-1107.
7.Ding J., Patton N., Deary I. J., Strachan M. W., Fowkes F. G., Mitchell R. J., Price J. F. Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. Br J Ophthalmol, 2008, vol. 92, no. 8, pp. 1017-1025.
8.Wong T. Y., Klein R., Klein B. E., Tielsch J. M., Hubbard L., Nieto F. J. Retinal microvscular abnormalities and they relationship with hypertension? Cardiovascular diseases and mortality. Surv Ophthalmol. 2001, vol. 46, no. 1, pp. 59-80.
9.Wong T. Y., Klein R., Sharrett A. R., Couper.D.J., Klein B. E., Liao D. P., Hubbard L. D., Mosley T. H. Cerebral white matter lesion? Retinopathy and risk of clinical stroke: the Atherosclerosis Risk in Communities Study. JAMA, 2002, vol. 288, no. 1, pp. 67-74.
10.McGeechan K., Liew G., Macaskill P., Irwig L., Klein R., Klein B. E., Wang J. J., Mitchell P., Vingerling J. R., Dejong P. T., Witteman J. C., Breteler M. M., Shaw J., Zimmet P., Wong T. Y. Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med, 2009, vol. 151, no. 6, pp. 404-413.
11.Grosso A., Veglio F., Porta M., Grignolo F. M., Wong T. Y. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol, 2005, vol. 89, no. 12, pp. 1646-1654.
12.Feihl F., Liaudet L., Levy B. I., Waeber B. Hypertension and microvascular remodelling. Cardiovasc Res, 2008, vol. 78, no.2, pp. 274-285.
13.Cheung, C. Y., Ikram M. I., Chen C., Wong T. Y. Imaging retina to study dementia and stroke. Prog Retin Eye Res, 2017, vol. 57, pp. 89-107.
14.Kubarko A. I., Kubarko Yu.A., Aleksandrov D. A. [et al.] Izmeneniya pokazateley zritel'nych funkziykaksledstvieimarkernarusheniygemodinamikivsosudachmozga [Changes in the indices of visual functions as a consequence and a marker of hemodynamic disorders in the vessels of the brain]. Sbornik nauchnych trudov, posvyaschennyy 10-letnemu yubileyu sotrudnichestva mezhdu BGMU, intervenzionnymi kardiologami universiteta Zapadnogo Ontario (Kanada) i kardiologami RB. Minsk: Knigazbor, 2010.- S. 148-157. (in Russian).
15.Patton N., Aslam T., Macgillivray T., Pattie A., Deary I. J., Dhillon B. Retinal vascular image analysis as potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. JAnat, 2005, vol. 206, no. 4, pp. 319-348.
16.Mutlu U., Cremers L. G., de Groot M., Hofman A., Niessen W. J., van der Lugt A., Klaver C. C., Ikram M. A., Vernooij M. W., Ikram M. K. Retinal microvasculature and white matter microstructure: The Rotterdam Studyl. Neurology, 2016, vol. 87, no. 10, pp. 1003-1010.
17.Kubarko A. I., Kubarko N. P., Kubarko Yu.A., Buben E. A., Bur E. A. Sostoyaniesosudov setchatki, svetovoy i kontrastno-zvetovoy chuvstvitel'nosti u pazientov s arterial'noy gipertenziey [The state of the vessels of the retina, light and contrast-color sensitivity in patients with arterial hypertension]. Oftal'mologiya. Vostochnaya Evropa, 2014, no. 4(23), S. 223-231. (in Russian).
18.Wong T. Y., Klein R., Sharrett A. R., Nieto F. J., Boland L. L., Couper D. J., Mosley T. H., Klein B. E., Hubbard L. D., Szklo M. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke, 2002, vol. 33, no. 6, pp. 1487-1492.
19.Cooper L. S., Wong T. Y., Klein R., Sharrett A. R., Bryan R. N., Hubbard L. D., Couper D. J., Heiss G., Sorlie P. D. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke, 2006, vol. 37, no. 1, pp. 82-86.
20.Hughes A. D., Falaschetti E., Witt N., Wijetunge S., Thom S. A., Tillin T., Aldington S. J., Chaturvedi N. Association of Retinopathy and Retinal Microvascular Abnormalities With Stroke and Cerebrovascular Disease. Stroke, 2016, vol. 47, 11, pp. 2862-2864.
21.Liew G., Baker M. L., Wong T. Y., Hand P. J., Wang J. J., Mitchell P., De Silva D. A., Wong M. C., Rochtchina E., Lindley R. I., Wardlaw J. M., Hankey G. J. Differing Associations of White Matter Lesions and Lacunar Infarction with Retinal Microvascular Signs. Int J Stroke, 2014, vol. 9, no. 7, pp. 921-925.
22.Baker M. L., Hand P. J., Wang J. J., Wong T. Y. Retinal signs and stroke revisiting the link between the eye and brain. Stroke, 2008, vol. 39, no. 4, pp. 1371-1379.
23.Kawasaki R., Xie J., Cheung N., Lamoureux E., Klein R., Klein B. E., Cotch M. F., Sharrett A. R., Shea S., Wong T. Y. Retinal microvascular signs and risk of stroke: the Multi-Ethnic Study of Atherosclerosis (MESA). Stroke, 2012, vol. 43, no. 12, pp. 3245-3251.
24.Cheung C. Y., Tay W. T., Ikram M. K., Ong Y. T., De Silva D. A., Chow K. Y., Wong T. Y. Retinal microvascular changes and risk of stroke: the Singapore Malay Eye Study. Stroke, 2013, vol. 44, no. 9, pp. 2402-2408.
25.Patton N., Pattie A., MacGillivray T., Aslam T., Dhillon B., Gow A., Starr J. M., Whalley L. J., Deary I. J. The association between retinal vascular network geometry and cognitive ability in an elderly population. Invest Ophthalmol Vis. Sc, 2007, vol. 48, no. 5, pp. 1995-2000.
26.Cheung C. Y., Ikram M. K., Sabanayagam C., Wong T. Y. Retinal microvasculature as a model to study the manifestations of hypertension. Hypertension, 2012, vol. 60, no. 5, pp. 1094-1103.
27.Nguen T. T., Wang J. J., Wong T. Y. Retinal Vascular Changes in Pre-Diabetes and Prehypertension. New findings and their research and clinical implications. Diabetes care, 2007, vol. 30, no. 10, pp. 2708-2715.
28.Aleksandrov D. A., Kubarko A. I. Izmenenie porogov svetovoy chuvstvitel'nosti zritel'noy sistemy v usloviyach lokal'nogo temperaturnogo vozd eystviya i ee zavisimost' ot sostoyaniya sistemnogo krovotoka [Change in thresholds of light sensitivity of the visual system under conditions of local temperature influence and its dependence on the state of the systemic blood flow]. Med. zhurnal, 2008, no. 1, S. 18-21 (in Russian).
29.Ascaso F. J., Cruz N., Modrego P. J., Lopez-Anton R., Santabarbara J., Pascual L. F., Lobo A., Cristobal J. A. Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. J. Neurol, 2014, vol. 261, no. 8, pp. 1522-1530.
30.Heringa S. M., Bouvy W. H., van den Berg E., Moll A. C., Kappelle L. J., Biessels G. J. Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. J Cereb Blood Flow Metab, 2013, vol. 33, no. 7, pp. 983-995.
31.O'Rourke M. F. Safar M. E. Relationship Between Aortic Stiffening and Microvascular Disease in Brain and Kidney. Cause and Logic of Therapy. Hypertension, 2005, vol. 46, pp. 200-204.
32.Ponomareva, M. N. Diagnostika i medikamentoznaya korrekziya narusheniy gemodinamiki pri ishemicheskoy neyropatii zriteknogo nerva u bolnych s serdechno-sosudistymi zabolevaniyaml [Diagnosis and drug correction of hemodynamic disorders in ischemic neuropathy of the optic nerve in patients with cardiovascular diseases]: Diss. dokt. med. nauk: 14.01.07. M., 2010, 235 s. (in Russian).
33.Diker S., Has A. C., Kurne A., Gogmen R., Oguz K. K., Karabudak R. The association of cognitive impairment with gray matter atrophy and cortical lesion load in clinically isolated syndrome. MultSclerRelatDiscard, 2016, vol. 10, pp. 14-21.
34.van der Veen P. H., Geerlings M. I., Visseren F. L., Nathoe H. M., Mali W. P., van der Graaf Y., Muller M. Hypertensive Target Organ Damage and Longitudinal Changes in Brain Structure and Function The Second Manifestations of Arterial Disease - Magnetic Resonance Study. Hypertension, 2015, vol. 66, no. 6, pp. 1152-1158.
35.Wardlaw J. M., Smith E. E., Biessels G. J., Cordonnier C., Fazekas F., Frayne R., Lindley R. I., O'Brien J.T., Barkhof F., Benavente O. R., Black S. E., Brayne C., Breteler M., Chabriat H., Decarli C., de Leeuw F. E. [et al.] Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol, 2013, vol. 12, no. 8, pp. 822-838.
36.Hayreh, S. S. Blood Flow in the Optic Nerve Head and Factors that may Influence it. Prog Retin Eye Res, 2001, vol. 20, no. 5, pp. 595-624.
37.Feihl F., Liaudet L., Waeber B., Levy B. I. Hypertension, a disease of the microcirculation? Hypertension, 2006, vol. 48, no. 6, pp. 1012-1017.
38.Wong T. Y., Islam F. M., Klein R., Klein B. E., Cotch M. F., Castro C., Sharrett A. R., Shahar E. Retinal Vascular Caliber, Cardiovascular risk factors and Inflammation: The Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci, 2006, vol. 47, no. 6, pp. 2341-2350.
39.Sivak, J. M. The Aging Eye: Common Degenerative Mechanisms Between the Alzheimer's Brain and Retinal Disease. Invest Ophthalmoo Vis Sci, 2013, vol. 54, no. 1, pp. 871-880.
40.Ikram M. K., de Jong F. J., Vernooij M. W., Hofman A., Niessen W. J., van der Lugt A., Klaver C. C., Ikram M. A. Retinal Vascular Calibers Associate Differentially With Cerebral Gray Matter and White Matter Atrophy. Alzheimer Dis Assoc Disord, 2013, vol. 27, no. 4, pp. 351-355.
41.Pires P. W., Dams Ramos C. M., Matin N., Dorrance A. M. The effects of hypertension on the cerebral circulation. Am J Physiol Heart Circ Physiol, 2013, vol. 304, no. 12, pp. 1598¬1614.
42.Ferri C. P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P. R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet, 2005, vol. 366, no. 9503, pp. 2112-2117.
43.Kantarci K. Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease. Expert Rev. Neurother, 2005, vol. 5, no. 5, pp. 663-670.
44.Jennings J. R., Mendelson D. N., Muldoon M. F., Ryan C. M., Gianaros P. J., Raz N., Aizenstein H. Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure. J Hum Hypertens, 2012, vol. 26, no. 5, pp. 295-305.
45.Pantoni L., Garcia J. H. Pathogenesis of leukoaraiosis: a review. Stroke, 1997, vol. 28, no. 3, pp. 652-659.